Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands – A Markov Model

• Charles Christian Adarkwah,

  Affiliations CAPHRI School of Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands, Department of Medicine III, RWTH-University Hospital Aachen, Aachen, Germany

  ⨯
• Afschin Gandjour,

  Affiliation Frankfurt School of Finance & Management, Frankfurt, Germany

  ⨯
• Maren Akkerman,

  Affiliation Faculty of Medicine, RWTH-University Aachen, Aachen, Germany

  ⨯
• Silvia M. Evers

  * E-mail: s.evers@maastrichtuniversity.nl

  Affiliation CAPHRI School of Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands

  ⨯